In order to investigate the dynamic regulation changes of TFs from normal to cancer, we focused on the oncogenic TF—CREB1 and identified two differentially regulated target genes, TCAEL2 and MBNL1, experimentally validating the differential dependence of target’s mRNA expression on the expression level of CREB1 between normal and cancer. The gene discussed is CREB1; the disease is cancer.